Dartsbio Pharmaceuticals

PharmaceuticalsSeries BZhongshan, Chinadartsbio.com

Latest round

Series B

Last raised

Jan 2023

Total raised

$30M

Investors

7

About Dartsbio Pharmaceuticals

Established in 2017 and based in Zhongshan, China, Dartsbio Pharmaceuticals is an innovative antibody drug discovery and development company. The company's chief scientist officer and co-founder, Dr.D. from the Shanghai Institute of Pharmaceutical Sciences of the Chinese Academy of Sciences and a post-doctoral fellow at Oregon Health Sciences University. The company is headquartered in Zhongshan and has a subsidiary in Shanghai. In June 2024, it closed a strategic investment. The company's business is the innovative development of antibody drugs, with a particular focus on oncology and pain management. The company's self-developed products include a range of antibody drugs and drug conjugates. Its products are mainly used in biomedical research and clinical applications. The company generates revenue by advancing its proprietary pipeline of antibody drugs through various stages of clinical development and by licensing its intellectual property to pharmaceutical and biotechnology companies.

Who invested in Dartsbio Pharmaceuticals

7 investors across 2 rounds

See all investors in Dartsbio Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jan 20, 2023

    Amount

    $15M

    Investors

    Locked

  2. Series A

    Aug 31, 2021

    Amount

    $15M

    Investors

    Locked

Questions about Dartsbio Pharmaceuticals

Who invested in Dartsbio Pharmaceuticals?

Dartsbio Pharmaceuticals has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Dartsbio Pharmaceuticals raised?

Dartsbio Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Dartsbio Pharmaceuticals last raise money?

Dartsbio Pharmaceuticals's most recent round on record is a Series B, in Jan 2023.

What does Dartsbio Pharmaceuticals do?

Established in 2017 and based in Zhongshan, China, Dartsbio Pharmaceuticals is an innovative antibody drug discovery and development company.

Where is Dartsbio Pharmaceuticals headquartered?

Dartsbio Pharmaceuticals is headquartered in Zhongshan, China.

Which VCs invest in companies like Dartsbio Pharmaceuticals?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Dartsbio Pharmaceuticals's stage. Their profiles are linked below.

Raising like Dartsbio Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.